Breast Cancer Invasive Clinical Trial
Official title:
Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.
Prospective, multicentric, non-randomized phase II study evaluating the surgical treatment by mastectomy with immediate prosthetic breast reconstruction in patients with breast cancer and receiving adjuvant therapy by TomoTherapy +/-Chemotherapy. Patients with non-inflammatory and non-metastatic invasive mammary carcinoma will be included in this study. The study procedure will be a surgical treatment by mastectomy with immediate prosthetic breast reconstruction followed by an adjuvant therapy: TomoTherapy +/-Chemotherapy (radiation therapy alone or preceded by chemotherapy). The nature of the chemotherapy treatment will be decided according to the standards of each center. The patients will be followed for the study up to 36 months after the surgical procedure.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03664895 -
Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)
|
Phase 3 | |
| Recruiting |
NCT05505357 -
Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)
|
N/A | |
| Completed |
NCT03669705 -
No Axillary Surgery for Early Breast Cancer.
|
||
| Terminated |
NCT05012397 -
Milademetan in Advanced/Metastatic Solid Tumors
|
Phase 2 | |
| Recruiting |
NCT05877859 -
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
|
||
| Active, not recruiting |
NCT04398914 -
Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT05351424 -
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
|
N/A | |
| Completed |
NCT05300412 -
The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer
|
||
| Recruiting |
NCT04999917 -
Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer
|
N/A | |
| Recruiting |
NCT05910398 -
Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer
|
Phase 3 | |
| Completed |
NCT05019989 -
Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study
|
N/A | |
| Recruiting |
NCT06144944 -
Neoadjuvant Pyrotinib Versus Placebo Combined With Chemotherapy in HR-positive and HER2-low Early Breast Cancer
|
Phase 3 | |
| Recruiting |
NCT04891068 -
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT06268665 -
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
|
Phase 2 | |
| Completed |
NCT05463276 -
The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study
|
||
| Completed |
NCT04729647 -
Immature Granulocyte Count and Delta Neutrophil Index Factors for Axillary Metastasis of Breast Cancer
|
N/A | |
| Active, not recruiting |
NCT06234488 -
Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study
|
||
| Recruiting |
NCT00437879 -
Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment.
|
||
| Not yet recruiting |
NCT05939310 -
Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 Study
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05020860 -
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
|
Phase 2 |